WOW!!! BGM Medical is going public with an IPO estimated at $86.3 Million and will be listed on the NASDAQ Global Market with a symbol BGMD. With CONX the contract manufacturer for BGMD's lead product, BGH Galectin-3 medical test, this funding should have an enormous favorable impact on CONX's business and market valuation IMO.